Carl Zeiss Meditec (OTCMKTS:CZMWY) Trading Down 2.4% – Here’s Why

Carl Zeiss Meditec AG (OTCMKTS:CZMWY)’s stock price fell 2.4% during mid-day trading on Thursday . The stock traded as low as $50.84 and last traded at $50.94. 1,805 shares were traded during trading, a decline of 56% from the average session volume of 4,099 shares. The stock had previously closed at $52.16.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CZMWY. Barclays began coverage on shares of Carl Zeiss Meditec in a report on Tuesday, September 9th. They set an “overweight” rating for the company. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Carl Zeiss Meditec in a report on Tuesday, August 12th. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Carl Zeiss Meditec Stock Down 2.4%

The stock has a fifty day moving average of $51.01 and a two-hundred day moving average of $59.91.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.